Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer
Condition: Breast Cancer Female Intervention: Drug: Pyrotinib Sponsor: RenJi Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Hospitals | Neoadjuvant Therapy | Research | Study